ARTICLE | Company News
FDA approves Shire's Reminyl for AD
February 28, 2001 8:00 AM UTC
The FDA granted marketing approval to Shire Pharmaceuticals (LSE:SHP; SHPGY) and marketing partner Janssen Pharmaceutica Products (Beerse, Belgium) for SHP's Reminyl galantamine acetylcholinesterase i...